Literature DB >> 23377869

10 rare tumors that warrant a genetics referral.

Kimberly C Banks1, Jessica J Moline, Monica L Marvin, Anna C Newlin, Kristen J Vogel.   

Abstract

The number of described cancer susceptibility syndromes continues to grow, as does our knowledge on how to manage these syndromes with the aim of early detection and cancer prevention. Oncologists now have greater responsibility to recognize patterns of cancer that warrant referral for a genetics consultation. While some patterns of common cancers are easy to recognize as related to hereditary cancer syndromes, there are a number of rare tumors that are highly associated with cancer syndromes yet are often overlooked given their infrequency. We present a review of ten rare tumors that are strongly associated with hereditary cancer predisposition syndromes: adrenocortical carcinoma, carcinoid tumors, diffuse gastric cancer, fallopian tube/primary peritoneal cancer, leiomyosarcoma, medullary thyroid cancer, paraganglioma/pheochromocytoma, renal cell carcinoma of chromophobe, hybrid oncocytoic, or oncocytoma histology, sebaceous carcinoma, and sex cord tumors with annular tubules. This review will serve as a guide for oncologists to assist in the recognition of rare tumors that warrant referral for a genetic consultation.

Entities:  

Mesh:

Year:  2013        PMID: 23377869     DOI: 10.1007/s10689-012-9584-9

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  169 in total

1.  Beyond BRCA1 and BRCA2 wild-type breast and/or ovarian cancer families: germline mutations in TP53 and PTEN.

Authors:  A Blanco; B Graña; L Fachal; M Santamariña; J Cameselle-Teijeiro; C Ruíz-Ponte; A Carracedo; A Vega
Journal:  Clin Genet       Date:  2009-11-23       Impact factor: 4.438

Review 2.  National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md., USA, July 13-15, 1987.

Authors: 
Journal:  Neurofibromatosis       Date:  1988

Review 3.  Pediatric adrenal cortical carcinoma: brain metastases and relationship to NF-1, case reports and review of the literature.

Authors:  Aaron Scott Wagner; Julie M Fleitz; B K Kleinschmidt-Demasters
Journal:  J Neurooncol       Date:  2005-11       Impact factor: 4.130

4.  Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study.

Authors:  Anita Villani; Uri Tabori; Joshua Schiffman; Adam Shlien; Joseph Beyene; Harriet Druker; Ana Novokmet; Jonathan Finlay; David Malkin
Journal:  Lancet Oncol       Date:  2011-05-19       Impact factor: 41.316

5.  Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias.

Authors:  Roland Kruse; Arno Rütten; Nadine Schweiger; Eva Jakob; Micaela Mathiak; Peter Propping; Elisabeth Mangold; Michele Bisceglia; Thomas Ruzicka
Journal:  J Invest Dermatol       Date:  2003-05       Impact factor: 8.551

6.  Cancer Incidence in BRCA1 mutation carriers.

Authors:  Deborah Thompson; Douglas F Easton
Journal:  J Natl Cancer Inst       Date:  2002-09-18       Impact factor: 13.506

7.  Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome.

Authors:  Marietta E Kovacs; Janos Papp; Zoltan Szentirmay; Szabolcs Otto; Edith Olah
Journal:  Hum Mutat       Date:  2009-02       Impact factor: 4.878

Review 8.  Birt-Hogg-Dubé syndrome: diagnosis and management.

Authors:  Fred H Menko; Maurice A M van Steensel; Sophie Giraud; Lennart Friis-Hansen; Stéphane Richard; Silvana Ungari; Magnus Nordenskjöld; Thomas Vo Hansen; John Solly; Eamonn R Maher
Journal:  Lancet Oncol       Date:  2009-12       Impact factor: 41.316

9.  Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.

Authors:  E R Maher; A R Webster; F M Richards; J S Green; P A Crossey; S J Payne; A T Moore
Journal:  J Med Genet       Date:  1996-04       Impact factor: 6.318

10.  Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.

Authors:  Magali Olivier; David E Goldgar; Nayanta Sodha; Hiroko Ohgaki; Paul Kleihues; Pierre Hainaut; Rosalind A Eeles
Journal:  Cancer Res       Date:  2003-10-15       Impact factor: 12.701

View more
  8 in total

1.  American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers.

Authors:  Karen H Lu; Marie E Wood; Molly Daniels; Cathy Burke; James Ford; Noah D Kauff; Wendy Kohlmann; Noralane M Lindor; Therese M Mulvey; Linda Robinson; Wendy S Rubinstein; Elena M Stoffel; Carrie Snyder; Sapna Syngal; Janette K Merrill; Dana Swartzberg Wollins; Kevin S Hughes
Journal:  J Clin Oncol       Date:  2014-02-03       Impact factor: 44.544

2.  Rare germline alterations in cancer-related genes associated with the risk of multiple primary tumor development.

Authors:  Rolando A R Villacis; Tatiane R Basso; Luisa M Canto; Maísa Pinheiro; Karina M Santiago; Juliana Giacomazzi; Cláudia A A de Paula; Dirce M Carraro; Patrícia Ashton-Prolla; Maria I Achatz; Silvia R Rogatto
Journal:  J Mol Med (Berl)       Date:  2017-01-16       Impact factor: 4.599

Review 3.  Genetic causes of cancer predisposition in children and adolescents.

Authors:  Federica Saletta; Luciano Dalla Pozza; Jennifer A Byrne
Journal:  Transl Pediatr       Date:  2015-04

Review 4.  A Guide to Pheochromocytomas and Paragangliomas.

Authors:  Julie Guilmette; Peter M Sadow
Journal:  Surg Pathol Clin       Date:  2019-09-28

5.  Cascade Fumarate Hydratase mutation screening allows early detection of kidney tumour: a case report.

Authors:  Melanie M Y Chan; Angela Barnicoat; Faiz Mumtaz; Michael Aitchison; Lucy Side; Helen Brittain; Alan W H Bates; Daniel P Gale
Journal:  BMC Med Genet       Date:  2017-07-26       Impact factor: 2.103

6.  A new mutL homolog 1 c.1896+5G>A germline mutation detected in a Lynch syndrome-associated lung and gastric double primary cancer patient.

Authors:  Xuyuan Chen; Xiang Li; Hongsen Liang; Lichun Wei; Qiang Cui; Ming Yao; Xu Wu
Journal:  Mol Genet Genomic Med       Date:  2019-06-17       Impact factor: 2.183

7.  Using family history forms in pediatric oncology to identify patients for genetic assessment.

Authors:  A Hamilton; E Smith; J Hamon; E Tomiak; M Bassal; S L Sawyer
Journal:  Curr Oncol       Date:  2017-12-20       Impact factor: 3.677

8.  Epidemiology of ovarian cancers in Zaria, Northern Nigeria: a 10-year study.

Authors:  Marliyya Sanusi Zayyan; Saad Aliyu Ahmed; Adekunle O Oguntayo; Abimbola O Kolawole; Tajudeen Ayodeji Olasinde
Journal:  Int J Womens Health       Date:  2017-11-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.